Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

25 Mar 2025 15:14

RNS Number : 1139C
Persimmon PLC
25 March 2025
 

 

25 March 2025

Persimmon Plc (the "Company")

Director/PDMR Shareholding

 

Persimmon Plc announces that on 24 March 2025 an award was granted to each of Dean Finch, Group Chief Executive, and Andrew Duxbury, Chief Financial Officer, over 135,040 and 88,621 shares respectively, under the Persimmon Plc 2017 Performance Share Plan. The three-year performance period will run from 1 January 2025 to 31 December 2027 and there is a further two-year holding period before the shares can be released to the Executive Directors.

 

Also on 24 March 2025 Dean Finch acquired 16,655 shares in the Company following the vesting of his 2020 Performance Share Plan award and 36,776 shares under the vesting of his 2021 Deferred Bonus Plan award, granted in 2022. He subsequently sold 25,151 of those shares to satisfy the tax liability arising on the exercise of his awards. The number of shares acquired includes shares awarded for dividend equivalents between the date of grant and date of vesting. 

 

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, gives further details:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Dean Finch

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Chief Executive

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Grant of award made under the 2017 Performance

Share Plan subject to performance criteria.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

135,040

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

24 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Andrew Duxbury

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Grant of award made under the 2017 Performance

Share Plan subject to performance criteria.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

88,621

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

24 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Dean Finch

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Chief Executive

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Acquisition of shares following the exercise of an option under the Persimmon Plc 2017 Performance Share Plan granted in 2020.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

16,655

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

24 March 2025

f)

Place of the transaction

 

Outside a trading venue

Transaction 2

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Acquisition of shares following the exercise of an option under the Persimmon 2020 Deferred Bonus Plan granted in 2022.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

36,776

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

24 March 2025

f)

Place of the transaction

 

Outside a trading venue

Transaction 3

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10p each

 

 

 

GB0006825383

 

b)

 

Nature of the transaction

 

 

Sale of shares to settle tax liability on exercise of share awards.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£11.755

25,151

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

24 March 2025

f)

Place of the transaction

 

London Stock Exchange (XLON); Main Market

 

 

Tracy Davison

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASDSAFDSEFA
Date   Source Headline
1st Jun 202610:06 amRNSAdmission to Trading
1st Jun 202610:03 amRNSTotal Voting Rights
29th May 202611:57 amRNSDirector/PDMR Shareholding
11th May 20264:56 pmRNSHolding(s) in Company
1st May 202612:12 pmRNSAdmission to Trading
1st May 202612:06 pmRNSTotal Voting Rights
30th Apr 20262:19 pmRNSResult of AGM
30th Apr 20262:18 pmRNSHolding(s) in Company
30th Apr 20267:00 amRNSAGM Trading Statement
23rd Apr 20269:21 amRNSHolding(s) in Company
1st Apr 20261:45 pmRNSAdmission to Trading
1st Apr 20261:43 pmRNSTotal Voting Rights
30th Mar 20263:06 pmRNSDirector/PDMR Shareholding
24th Mar 20263:20 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:12 pmRNSAnnual Report 2025 and Notice of AGM 2026
10th Mar 20267:00 amRNSFull Year Results
2nd Mar 202611:26 amRNSTotal Voting Rights
18th Feb 20261:33 pmRNSNew Issue of Equity Securities
2nd Feb 202610:00 amRNSTotal Voting Rights
13th Jan 20267:00 amRNS2025 Trading Statement
2nd Jan 202612:52 pmRNSTotal Voting Rights
2nd Jan 202611:09 amRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
1st Dec 20252:58 pmRNSBlock listing Interim Review
1st Dec 202512:39 pmRNSTotal Voting Rights
27th Nov 202511:47 amRNSHolding(s) in Company
13th Nov 20257:00 amRNSQ3 Trading Statement
3rd Nov 202511:43 amRNSTotal Voting Rights
1st Oct 202511:45 amRNSTotal Voting Rights
30th Sep 202512:58 pmRNSDirector/PDMR Shareholding
26th Sep 20255:33 pmRNSHolding(s) in Company
17th Sep 20254:44 pmRNSHolding(s) in Company
9th Sep 202510:14 amRNSDirector/PDMR Shareholding
1st Sep 20252:31 pmRNSTotal Voting Rights
13th Aug 20257:00 amRNSHalf Year Results
1st Aug 202511:36 amRNSTotal Voting Rights
9th Jul 20257:23 amRNSUK CMA proposes closure of its investigation
4th Jul 20251:44 pmRNSHolding(s) in Company
1st Jul 202511:38 amRNSTotal Voting Rights
17th Jun 20253:47 pmRNSHolding(s) in Company
2nd Jun 20253:07 pmRNSBlock listing Interim Review
2nd Jun 202511:39 amRNSTotal Voting Rights
14th May 20257:00 amRNSSale of FibreNest
1st May 20252:20 pmRNSResult of AGM
1st May 20252:02 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.